Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial (2025)
- Authors:
- Autor USP: ROCHA, VANDERSON GERALDO - FM
- Unidade: FM
- DOI: 10.1038/s41375-025-02608-4
- Subjects: LEUCEMIA; ANTINEOPLÁSICOS
- Agências de fomento:
- Language: Inglês
- Objetivos de Desenvolvimento Sustentável (ODS):
03. Saúde e bem-estar
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ASHAYE, Ajibade et al. Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial. Leukemia, v. 39, n. 6, p. 1342-1350, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/87063. Acesso em: 24 jan. 2026. -
APA
Ashaye, A., Shi, L., Aldoss, I., Montesinos, P., Vachhani, P., Rocha, V. G., et al. (2025). Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial. Leukemia, 39( 6), 1342-1350. doi:10.1038/s41375-025-02608-4 -
NLM
Ashaye A, Shi L, Aldoss I, Montesinos P, Vachhani P, Rocha VG, Papayannidis C, Leonard JT, Baer MR, Ribera J-M. Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial [Internet]. Leukemia. 2025 ; 39( 6): 1342-1350.[citado 2026 jan. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/87063 -
Vancouver
Ashaye A, Shi L, Aldoss I, Montesinos P, Vachhani P, Rocha VG, Papayannidis C, Leonard JT, Baer MR, Ribera J-M. Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial [Internet]. Leukemia. 2025 ; 39( 6): 1342-1350.[citado 2026 jan. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/87063 - Risk factors affecting outcome of unrelated cord blood transplantation for children with familial haemophagocytic lymphohistiocytosis
- Defining the clinical relevance of red blood cell autoantibodies by Monocyte Monolayer Assay
- Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies
- Anticancer cellular immunotherapies derived from umbilical cord blood
- Atrichia with Papular Lesions: importance of histology at an early disease stage
- Low body mass index is associated with increased risk of acute GVHD after umbilical cord blood transplantation in children and young adults with acute leukemia: a study on behalf of Eurocord and the EBMT pediatric disease working party
- The impact of pretransplant malnutrition on allogeneic hematopoietic stem cell transplantation outcomes
- Detection of bacterial contamination in platelet concentrates from Brazilian donors by molecular amplification of the ribosomal 16S gene
- Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR
- BRAF V600E mutation detected in a case of Rosai-Dorfman disease
Informações sobre o DOI: 10.1038/s41375-025-02608-4 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
